Who We Are
MolecularMD Provides Clients with a Full-service Diagnostics Offering Designed to Accelerate Oncology Drug Approval
MolecularMD (MMD) streamlines the codevelopment and commercialization of molecular diagnostic tests that are deployed and leveraged across the continuum of the drug development process. Our capabilities are broad with significant scientific capabilities, which include:
- Assay design and development services
- Sample banking and bridging strategies
- Clinical trial design
- Regulatory planning
- Analytical and clinical assay validation
- Full-service histology and pathology offerings; including immunohistochemistry (IHC) assay development
- FDA submission services
- Custom clinical GMP kit manufacturing.
MMD works with its clients to manage risks and optimize their ROI by providing flexible, platform-agnostic diagnostic services, an uncommon approach and one that is not well served by contract research organizations (CROs) or in-vitro diagnostic platform providers. For over 10 years, the company has developed an exceptional reputation among both industry and FDA regulatory leaders.
Learn more about MolecularMD’s unique capabilities.